- Investor's Business Daily•3 hours ago
Gilead's NASH drug is "clearly active and promising," but Intercept Pharmaceuticals remains one to two years ahead, RBC says.
- Zacks•9 hours ago
Allergan plc (AGN) and partner Serenity Pharmaceuticals announced that the FDA's Advisory Committee recommended approval for its pipeline candidate SER120 (desmopressin nasal spray) for the treatment of nocturia.
Allergan plc (AGN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||230.20 x 800|
|Ask||233.20 x 2000|
|Day's Range||229.33 - 232.41|
|52wk Range||195.50 - 322.68|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.94|
|Avg Vol (3m)||3,291,155|
|Dividend & Yield||N/A (N/A)|